Legal Opinion

In Re Yasmin & Yaz (Drospirenone) Marketing, Sales Practices & Products Liability Litigation

United States Judicial Panel on Multidistrict Litigation

Decided October 1, 2009No. MDL No. 2100PublishedCited by 3 opinions

1Opinion of the Court

TRANSFER ORDER

ROBERT L. MILLER, JR., Acting Chairman.

Before the entire Panel * : Plaintiffs in 24 actions and three related actions move, pursuant to 28 U.S.C. § 1407, for coordinated or consolidated pretrial proceedings of the 32 actions listed on Schedule A in the Northern District of Ohio. The plaintiffs’ motion encompasses fourteen actions in the Northern District of Ohio, six actions in the Eastern District of Pennsylvania, five actions in the Northern District of California, two actions in the Southern District of Ohio, and one action each in the Eastern District of California, Northern…

2Cases cited2 opinions

  1. In Re Avandia Marketing, Sales PracticesUnited States Judicial Panel on Multidistrict Litigation · 2007
  2. In Re Vytorin/Zetia Marketing, Sales Practices & Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2008

3Cited by3 opinions

  1. In Re Darvocet, Darvon & Propoxyphene Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2011
  2. In re Valsartan N-Nitrosodimethylamine (Ndma) Contamination Prods. Liab. Litig.United States Judicial Panel on Multidistrict Litigation · 2019
  3. In re Pradaxa (Dabigatran Etexilate) Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2012

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API